China SXT Pharmaceuticals ( NASDAQ: SXTC ) has received a notification letter, that the minimum bid price/share for its ordinary shares has been below $1 for a period of 30 consecutive business days and the Co. therefore no longer meets the minimum bid price requirements. The notification received has no immediate effect on the listing of the Co.
’s ordinary shares on Nasdaq. Under the Nasdaq Listing Rules, the Co. has until April 1, 2025, to regain compliance.
More on China SXT Pharmaceuticals Financial information for China SXT Pharmaceuticals.
